Literature DB >> 27884251

Complicated Pericarditis: Understanding Risk Factors and Pathophysiology to Inform Imaging and Treatment.

Paul C Cremer1, Arnav Kumar1, Apostolos Kontzias2, Carmela D Tan3, E Rene Rodriguez3, Massimo Imazio4, Allan L Klein5.   

Abstract

Most patients with acute pericarditis have a benign course and a good prognosis. However, a minority of patients develop complicated pericarditis, and the care of these patients is the focus of this review. Specifically, we address risk factors, multimodality imaging, pathophysiology, and novel treatments. The authors conclude that: 1) early high-dose corticosteroids, a lack of colchicine, and an elevated high-sensitivity C-reactive protein are associated with the development of complicated pericarditis; 2) in select cases, cardiovascular magnetic resonance imaging may aid in the assessment of pericardial inflammation and constriction; 3) given phenotypic similarities between recurrent idiopathic pericarditis and periodic fever syndromes, disorders of the inflammasome may contribute to relapsing attacks; and 4) therapies that target the inflammasome may lead to more durable remission and resolution. Finally, regarding future investigations, the authors discuss the potential of cardiovascular magnetic resonance to inform treatment duration and the need to compare steroid-sparing treatments to pericardiectomy.
Copyright © 2016 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  autoimmune diseases; cardiovascular magnetic resonance imaging; colchicine; inflammasome; inflammation; pericardiectomy

Mesh:

Substances:

Year:  2016        PMID: 27884251     DOI: 10.1016/j.jacc.2016.07.785

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  45 in total

Review 1.  New Cardiac Imaging Algorithms to Diagnose Constrictive Pericarditis Versus Restrictive Cardiomyopathy.

Authors:  Ahmad Mahmoud; Manish Bansal; Partho P Sengupta
Journal:  Curr Cardiol Rep       Date:  2017-05       Impact factor: 2.931

Review 2.  Recurrent pericarditis: still idiopathic? The pros and cons of a well-honoured term.

Authors:  Antonio Brucato; Massimo Imazio; Paul C Cremer; Yehuda Adler; Bernhard Maisch; George Lazaros; Marco Gattorno; Alida L P Caforio; Renzo Marcolongo; Giacomo Emmi; Alberto Martini; Allan L Klein
Journal:  Intern Emerg Med       Date:  2018-07-18       Impact factor: 3.397

Review 3.  The Role of Epicardial Fat in Pericardial Diseases.

Authors:  George Lazaros; Alexios Antonopoulos; Charalambos Antoniades; Dimitris Tousoulis
Journal:  Curr Cardiol Rep       Date:  2018-04-19       Impact factor: 2.931

4.  Acute pericarditis: Update on diagnosis and management.

Authors:  Tevfik F Ismail
Journal:  Clin Med (Lond)       Date:  2020-01       Impact factor: 2.659

Review 5.  Uremic pericarditis, pericardial effusion, and constrictive pericarditis in end-stage renal disease: Insights and pathophysiology.

Authors:  Karim Abdur Rehman; Jorge Betancor; Bo Xu; Arnav Kumar; Carlos Godoy Rivas; Kimi Sato; Leslie P Wong; Craig R Asher; Allan L Klein
Journal:  Clin Cardiol       Date:  2017-09-05       Impact factor: 2.882

Review 6.  New Insights into Pericarditis: Mechanisms of Injury and Therapeutic Targets.

Authors:  Bo Xu; Serge C Harb; Paul C Cremer
Journal:  Curr Cardiol Rep       Date:  2017-07       Impact factor: 2.931

Review 7.  Multimodality Imaging for the Assessment of Pericardial Diseases.

Authors:  Michael Chetrit; Bo Xu; Beni R Verma; Allan L Klein
Journal:  Curr Cardiol Rep       Date:  2019-04-16       Impact factor: 2.931

Review 8.  Use of Interleukin-1 Blockers in Pericardial and Cardiovascular Diseases.

Authors:  Giacomo Emmi; Maria Letizia Urban; Massimo Imazio; Marco Gattorno; Silvia Maestroni; Giuseppe Lopalco; Luca Cantarini; Domenico Prisco; Antonio Brucato
Journal:  Curr Cardiol Rep       Date:  2018-06-14       Impact factor: 2.931

Review 9.  Colchicine in Pericardial Disease: from the Underlying Biology and Clinical Benefits to the Drug-Drug Interactions in Cardiovascular Medicine.

Authors:  Aldo L Schenone; Venu Menon
Journal:  Curr Cardiol Rep       Date:  2018-06-14       Impact factor: 2.931

Review 10.  Management of idiopathic recurrent pericarditis in adults and in children: a role for IL-1 receptor antagonism.

Authors:  Antonio Brucato; Giacomo Emmi; Luca Cantarini; Andrea Di Lenarda; Marco Gattorno; Giuseppe Lopalco; Renzo Marcolongo; Massimo Imazio; Alberto Martini; Domenico Prisco
Journal:  Intern Emerg Med       Date:  2018-04-09       Impact factor: 3.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.